fluconazole has been researched along with fluorouracil in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.69) | 18.2507 |
| 2000's | 8 (30.77) | 29.6817 |
| 2010's | 13 (50.00) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chapeland-Leclerc, F; Chastin, C; Florent, M; Gibot-Leclerc, S; Jean, D; Noël, T; Papon, N; Villard, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Kumar, P; Majeed, AB; Mani, V; Mishra, RK; Narasimhan, B; Ramasamy, K; Sharma, SK | 1 |
| Hamid, A; Jaglan, S; Klapötke, TM; Kumar, D; Narasimhan, B; Qazi, AK; Singh, K; Stierstorfer, J; Verma, V | 1 |
| El-Gohary, NS; Shaaban, MI | 3 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chanu, MB; Mahendra, M; Puttaraju, KB; Rai, K; Rasal, VP; Shivashankar, K; Venkata Vivek, PN | 1 |
| Chen, PJ; Gu, YF; He, P; Jiang, TF; Liu, HM; Shao, KP; Xue, DQ; Yang, A; Zhang, QR; Zhang, XS | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abdel-Rahman, SA; El-Ashry, SM; El-Bendary, ER; El-Gohary, NS; Shaaban, MI | 1 |
| Dinh Thanh, N; Minh Tri, N; Ngoc Toan, V; Thi Thu Huong, N | 1 |
| Han, H; Qi, XR; Shen, L; Tang, HF; Xu, QZ; Yang, WS; Yi, YH; Yuan, CH | 1 |
| Koga, H; Kono, S | 1 |
| Arranz-Caso, JA; García-Altozano, J; Gomez-Herruz, P; Lopez-Pizarro, VM; Martinez-Martinez, J | 1 |
| Aboagye, EO; Price, PM; Saleem, A | 1 |
| Nakanishi, T; Sekimizu, K | 1 |
| Yamaguchi, H | 1 |
| Bive, BZ; Bontems, S; Hayette, MP; Lelo, GM; Mudogo, CN; Sacheli, R; Zakayi, PK | 1 |
3 review(s) available for fluconazole and fluorouracil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
In vivo monitoring of drugs using radiotracer techniques.
Topics: Drug Administration Schedule; Drug Monitoring; Fluconazole; Fluorouracil; Humans; Models, Biological; Radionuclide Imaging; Receptors, Cell Surface; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
[Antifungal drug].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Design; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fluorouracil; Fungi; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Polyenes; Pyrimidines | 2003 |
23 other study(ies) available for fluconazole and fluorouracil
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance.
Topics: Alleles; Antifungal Agents; Candida; Cloning, Molecular; Cytosine Deaminase; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fluorouracil; Fungal Proteins; Genetic Complementation Test; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Pentosyltransferases; Plasmids; Sequence Analysis, DNA | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Synthesis, antimicrobial, anticancer evaluation and QSAR studies of 6-methyl-4-[1-(2-substituted-phenylamino-acetyl)-1H-indol-3-yl]-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid ethyl esters.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Cell Survival; HCT116 Cells; Humans; Indoles; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Quantitative Structure-Activity Relationship; Spectroscopy, Fourier Transform Infrared | 2012 |
Synthesis, antimicrobial and cytotoxicity study of 1,3-disubstituted-1H-naphtho[1,2-e][1,3]oxazines.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus niger; Candida albicans; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured | 2012 |
Synthesis, antimicrobial, antiquorum-sensing, antitumor and cytotoxic activities of new series of fused [1,3,4]thiadiazoles.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Artemia; Candida albicans; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Escherichia coli; HCT116 Cells; HL-60 Cells; HT29 Cells; Humans; K562 Cells; Lethal Dose 50; MCF-7 Cells; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Quorum Sensing; Staphylococcus aureus; Structure-Activity Relationship; Thiadiazoles | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Microwave assisted synthesis of dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones; synthesis, in vitro antimicrobial and anticancer activities of novel coumarin substituted dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Screening Assays, Antitumor; Fungi; Humans; Microbial Sensitivity Tests; Microwaves; Models, Molecular; Molecular Structure; Pyrimidinones | 2013 |
Synthesis, in vitro antimicrobial and cytotoxic activities of novel pyrimidine-benzimidazol combinations.
Topics: Anti-Infective Agents; Bacteria; Benzimidazoles; Candida albicans; Cell Line, Tumor; Cell Survival; Combinatorial Chemistry Techniques; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines | 2014 |
Synthesis and biological evaluation of a new series of benzimidazole derivatives as antimicrobial, antiquorum-sensing and antitumor agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fungi; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2017 |
Synthesis, antimicrobial, antiquorum-sensing and antitumor activities of new benzimidazole analogs.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Aspergillus fumigatus; Bacillus cereus; Benzimidazoles; Candida albicans; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Escherichia coli; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Quorum Sensing; Staphylococcus aureus; Structure-Activity Relationship | 2017 |
Synthesis, antimicrobial, antiquorum-sensing, antitumor and cytotoxic activities of new series of cyclopenta(hepta)[b]thiophene and fused cyclohepta[b]thiophene analogs.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Cell Line; Cell Proliferation; Cycloheptanes; Cyclopentanes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fungi; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship; Thiophenes | 2017 |
Synthesis and biological screening of thiosemicarbazones of substituted 3-acetylcoumarins having d-glucose moiety.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Coumarins; Fungi; Glucose; Humans; Microbial Sensitivity Tests; Mycoses; Structure-Activity Relationship; Thiosemicarbazones | 2020 |
A new sulfated triterpene glycoside from the sea cucumber Colochirus quadrangularis, and evaluation of its antifungal, antitumor and immunomodulatory activities.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Glycosides; Humans; Immunomodulation; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Saponins; Sea Cucumbers; Triterpenes | 2021 |
[Diagnosis and therapy of pulmonary mycoses].
Topics: Adolescent; Adult; Aged; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Fluorouracil; Humans; Lung Diseases, Fungal; Male; Middle Aged; Serologic Tests | 1993 |
Candida albicans osteomyelitis of the zygomatic bone. A distinctive case with a possible peculiar mechanism of infection and therapeutic failure with fluconazole.
Topics: Administration, Inhalation; Amphotericin B; Biopsy; Candidiasis; Candidiasis, Oral; Diabetes Complications; Fluconazole; Fluorouracil; Humans; Male; Middle Aged; Osteomyelitis; Steroids; Zygoma | 1996 |
SDT1/SSM1, a multicopy suppressor of S-II null mutant, encodes a novel pyrimidine 5'-nucleotidase.
Topics: 5'-Nucleotidase; Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Escherichia coli; Fluconazole; Flucytosine; Fluorouracil; Fungal Proteins; Molecular Sequence Data; Nucleotidases; Phosphorylation; Protein Binding; Recombinant Proteins; Ribosomal Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Substrate Specificity | 2002 |
Correlation of antifungal susceptibility and sequence types within Cryptococcus neoformans VNI from HIV patients, and ERG11 gene polymorphism.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Democratic Republic of the Congo; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fluorouracil; HIV Infections; Humans; Microbial Sensitivity Tests; Polymorphism, Genetic | 2023 |